Combined randomised controlled trial experience of malignancies in studies using insulin glargine.

Home, P D; Lagarenne, P
Diabetologia; 2009 Dec;52(12):2499-506. PMID: 19756478
ICM-Diabetes, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK.


Recent publications of data extracted from population registries have suggested a possible relationship between treatment with insulin glargine and increased incidence of cancer/breast cancer. The aim of the present study was investigate this possible relationship using data from the manufacturer's (sanofi-aventis) pharmacovigilance database.